## Company Overview
OpenEvidence is described as the leading medical information platform, launched from the Mayo Clinic Platform Accelerate program. The company's mission is to organize and expand the world's collective medical knowledge, addressing the challenge of information overload in medicine. OpenEvidence aggregates, synthesizes, and visualizes clinically relevant evidence in understandable formats to aid healthcare professionals in making evidence-based decisions and improving patient outcomes.

## Business Model and GTM
OpenEvidence is free and unlimited for healthcare professionals (HCPs) in the U.S. The company has signed content agreements with JAMA and The New England Journal of Medicine, featuring multimedia and clinical findings from these prestigious sources. The company states that it aims to tame the medical information firehose, which is crucial given the rapid increase in medical research published annually.

## Funding & Investor Profile
OpenEvidence has received backing from notable investors including Sequoia, Google Ventures, Kleiner Perkins, Coatue, Thrive, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, Blackstone, and Mayo Clinic, among others.

## Growth Momentum
Not disclosed.

## Visibility & Market Sentiment
The company states that the amount of medical research published annually is doubling every five years, indicating a growing market need for their services. OpenEvidence's partnerships with reputable medical journals suggest a positive market sentiment towards its offerings.

## Risks and Challenges
Not disclosed.

## Outlook
Not disclosed.

## Disclosure Gaps
- Specific details on growth momentum, including user metrics or revenue figures, are not disclosed.
- Risks and challenges faced by the company are not disclosed.
- Future outlook or strategic plans are not disclosed.
